Biomarker Profiling of Radiation and DDR Inhibitor Combinations in LNCaP Xenografts

AACR 2026 Poster | Ionising radiation induces DNA damage primarily through the formation of single and double strand breaks, which, if unrepaired, can lead to cell death. These breaks activate the DNA damage response. (DDR) which is a network of cellular pathways that detect and repair any DNA damage and includes the phosphorylation of proteins like H2AX and DNA-PK.

When damage is extensive or incorrectly repaired, this can result in genomic instability, apoptosis, or senescence. In drug discovery, this mechanism can be exploited by combining targeted delivery of ionising radiation to cancer cells with inhibition of key DDR proteins, thereby preventing repair and promoting tumour cell death.

Biomarkers of radiosensitivity and DNA damage are therefore critical for both preclinical and clinical evaluation of novel combination therapies.

Meet the team at AACR 2026 at Booth 1418, Hall C (Ground Level).


Scientist in lab



View the poster here

 

 







News
22 September 2026
New standardised, contemporary strain panels address a long-standing barrier in AMR research

PACE (Pathways to Antimicrobial Clinical Efficacy) and the UK Health Security Agency (UKHSA) have released five new contemporary antimicrobial resistance (AMR) strain panels, giving innovators worldwide a resource to test novel therapeutics and diagnostics against today’s resistance patterns.


new board appointments
News
15 September 2026
Medicines Discovery Catapult appoints global life science and commercialisation leaders to its Board of Directors

New appointments support MDC’s mission to turn drug discovery into commercial breakthroughs.





Medicines Discovery Catapult